{
    "id": "MISSION50-39-1772034670723",
    "type": "dragAndDropCloze",
    "stem": "A patient is receiving heparin and warfarin concurrently for treatment of a deep vein thrombosis (DVT). The patient's aPTT is 90 seconds (therapeutic range 60-80 seconds) and INR is 1.2 (therapeutic range 2.0-3.0). Based on these lab values, the nurse should {{blank1}} the heparin infusion and {{blank2}} the warfarin dosage.",
    "template": "Based on these lab values, the nurse should {{blank1}} the heparin infusion and {{blank2}} the warfarin dosage.",
    "scoring": {
        "method": "polytomous",
        "maxPoints": 2
    },
    "rationale": {
        "correct": "The patient's aPTT is elevated above the therapeutic range, indicating that the heparin is having too strong of an effect. The heparin infusion should be decreased to prevent bleeding complications. The patient's INR is below the therapeutic range, indicating that the warfarin is not yet effective. The warfarin dosage should be increased to achieve therapeutic anticoagulation. Overlap is needed because warfarin takes several days to reach therapeutic levels.",
        "incorrect": "Increasing the heparin would further elevate the aPTT and increase the risk of bleeding. Decreasing the warfarin dosage would further reduce the INR and delay therapeutic anticoagulation. Discontinuing heparin when INR is subtherapeutic increases risk of clot extension. Maintaining current doses would not correct the lab abnormalities.",
        "clinicalPearls": [
            "Heparin and warfarin are often used concurrently to achieve therapeutic anticoagulation quickly while waiting for warfarin to reach therapeutic levels.",
            "Monitor aPTT for heparin and INR for warfarin. Adjust dosages based on these lab values.",
            "Educate patients about the importance of regular lab monitoring and signs/symptoms of bleeding."
        ],
        "questionTrap": {
            "trap": "Students may confuse the lab values for heparin (aPTT) and warfarin (INR) or misinterpret therapeutic ranges.",
            "howToOvercome": "Memorize the therapeutic ranges for aPTT and INR. Associate aPTT with heparin and INR with warfarin. Use a table to organize the information."
        },
        "mnemonic": {
            "title": "HI",
            "expansion": "Heparin = aPTT, INR = Warfarin"
        },
        "reviewUnits": [
            {
                "title": "Heparin and Warfarin Anticoagulation",
                "content": "Review the mechanisms of action, therapeutic uses, monitoring parameters, and adverse effects of heparin and warfarin."
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 4,
        "topicTags": [
            "anticoagulation",
            "heparin",
            "warfarin",
            "pharmacology"
        ]
    },
    "itemContext": {
        "patient": {
            "name": "Jane Doe",
            "age": 62,
            "gender": "Female",
            "allergies": [
                "Penicillin"
            ],
            "iso": "standard"
        },
        "sbar": "0700: Patient Jane Doe, 62 yo female, admitted for DVT treatment. Currently on heparin drip and warfarin. 0715: Patient reports no new pain or discomfort. No signs of bleeding noted. 0730: Noted aPTT of 90 seconds and INR of 1.2. Heparin per protocol. Warfarin 5mg PO daily. 0745: Patient denies any new medication changes. No current complaints. VS stable. 0800: Notified provider of lab results. Orders received to decrease heparin and increase warfarin. Orders transcribed and verified. 0815: Will continue to monitor labs and assess for bleeding. Patient education provided regarding medication changes and monitoring.",
        "tabs": [
            {
                "id": "sbar",
                "title": "Nurses Notes",
                "content": "0600: Patient states, 'My leg feels better today.' No redness, swelling, or tenderness noted in left calf. Pedal pulses palpable bilaterally. 0800: aPTT 90 seconds, INR 1.2. Provider notified. Orders received and implemented. 0830: Heparin infusion decreased per order. Warfarin dose increased per order. Patient tolerating changes well. No signs of bleeding observed."
            },
            {
                "id": "labs",
                "title": "Lab Diagnostics",
                "content": "Na 139 mEq/L | K 4.1 mEq/L | Cl 100 mEq/L | HCO3 25 mEq/L | BUN 15 mg/dL | Creatinine 0.8 mg/dL | aPTT 90 seconds | INR 1.2 | Hemoglobin 12.5 g/dL | Hematocrit 37% | Platelets 250,000/mcL"
            },
            {
                "id": "vitals",
                "title": "Vital Signs",
                "content": "0600: HR 78 bpm, BP 130/80 mmHg, RR 16 breaths/min, SpO2 98% on room air, Temp 98.6째F (37째C) Oral | 0800: HR 80 bpm, BP 128/78 mmHg, RR 16 breaths/min, SpO2 98% on room air, Temp 98.6째F (37째C) Oral"
            },
            {
                "id": "mar",
                "title": "MAR",
                "content": "Heparin infusion 1000 units/hr | Warfarin 5 mg PO daily | Acetaminophen 650mg PO PRN for pain | Docusate 100mg PO daily"
            }
        ]
    },
    "blanks": [
        {
            "id": "blank1",
            "options": [
                "decrease",
                "increase",
                "hold",
                "maintain"
            ],
            "correctOption": "decrease"
        },
        {
            "id": "blank2",
            "options": [
                "increase",
                "decrease",
                "hold",
                "maintain"
            ],
            "correctOption": "increase"
        }
    ],
    "sentinelStatus": "healed_v2026_v11"
}